InvestorsHub Logo
Followers 271
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Re: None

Wednesday, 01/05/2022 5:59:30 AM

Wednesday, January 05, 2022 5:59:30 AM

Post# of 458205
Looking forward to Jan 13th! $AVXL

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, will present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 8:15 am Pacific Time / 11:15 am Eastern Time at the Westin St. Francis Hotel in San Francisco, CA.
A live webcast of the presentation, as well as an archived recording, will be available at https://jpmorgan.metameetings.net/events/healthcare22/sessions/40488-anavex-life-sciences-corp/webcast?gpu_only=true&kiosk=true and in the Investors section of the Company's website at www.anavex.com.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News